Abstract: A series of 9 phenoxyacetic acids substituted in the o-, m-, and p-position of benzene ring with 2-(2-oxo-1-azacycloalkyl)acetamidic moiety containing 5-7-membered -lactam ring was prepared by a 4-step synthetic procedure. Five selected substances of this series were tested in vitro for inhibition of porcine kidney aminopeptidase M. 2-{4-[2-(2-Oxoperhydroazepin-1-yl)acetamido]phenoxy}acetic acid exhibited the highest activity with K i = 243.6 M.
INTRODUCTION
Aminopeptidases are hydrolases cleaving N-terminal amino acid residue from a peptide chain. They are present in all organisms from bacteria to humans and play important roles in many metabolic pathways and regulatory processes. 1, 2 Aminopeptidase M (EC 3.4.11.2, aminopeptidase N, membrane alanyl aminopeptidase, AP-M) is a metallo-dependent integral membrane protease. This enzyme belongs to the M1 family of the MA clan of peptidases, also called gluzincins. 3 At least nine different enzymes, five of which are integral membrane proteins, were recently discovered as members of the M1 family in mammals. 4 Aminopeptidase M has a molecular weight of about 110,000 and consists of 963--967 amino acids residues, depending on the species. It has a short N-terminal cytoplasmic domain, a single transmembrane part and a large cellular ectodomain containing the active site. 5 This enzyme was first isolated in 1963 by Pfleiderer and Celliers from pig kidney 6 and is also known as pseudo leucine aminopeptidase and under several other names originating from the processes in which it participates. This peptidase preferentially cleaves peptides with an N-terminal active ligand of the AT 4 receptor 14 and can probably be useful for the enhancement of learning performance and treatment of Alzheimer disease. 15 For this reason, it was considered to be useful to test our newly prepared 2-{[2-oxo-1--azacycloalk-1-yl)acetamido]phenoxy}acetic acids for their ability to influence the activity of AP-M, because they were designed as candidate CNS therapeutic agents, potential cognitive enhancers*, as they contain fragments of 2-(2-oxopyrrolidin-1-yl)acetamide (classical nootropic piracetam) and phenoxyacetic acid, * Some of these substances have been mentioned in literature in the context of the determination of their pK a values by CZE. 16 We provided these compounds, prepared originally by us, to the authors of this paper, but they unfortunately published the results of their determinations with neither mentioning us in the Acknowledgements nor giving us notice of the publication.
which is present in the molecule of meclofenoxate (2-(dimethylamino)ethyl 4-chlorophenoxyacetate, a cognitive enhancer, Fig. 1 ). 
EXPERIMENTAL

Chemistry
General. All melting points were determined on a Boetius PHMK apparatus (Nagema, Dresden, Germany) and are uncorrected. Elemental analyses (C, H, N) were performed with a Perkin-Elmer 2400 CHNS/O analyzer. The IR spectra were measured on a Nicolet Impact FTIR spectrometer. Nitrophenoxyacetic acids. Nitrophenol (50.0 g, 0.36 mol) was added to a solution of 27.8 g (0.70 mol) of sodium hydroxide in 280 ml of water. The resulting solution was heated to 80 °C and 34.0 g (0.36 mol) of chloroacetic acid was added. This mixture was refluxed for 24 h, then cooled and acidified with concentrated hydrochloric acid (≈ pH 0). This solution was let to crystallize in a refrigerator for several hours. Chloroacetamidophenoxyacetic acids. Nitrophenoxyacetic acid (10.0 g, 0.060 mol) was dissolved in 18 ml of ca. 13 % aqueous ammonia under heating. The resulting solution was added under stirring to a boiling solution of 100.0 g (0.360 mol) of ferrous sulfate heptahydrate in 200 ml of water and this mixture was refluxed for 25 min and, if the reaction of the liquid phase became neutral, it was alkalized with concentrated aqueous ammonia and then immediately filtered. An aqueous 10 % sodium hydroxide solution (36 ml) was added to the filtrate and the mixture was stirred for 10 min. Free ammonia and water were slowly distilled off on a rotary vacuum evaporator until a white precipitate of aminophenoxyacetic acid sodium salt appeared. Water was added until the precipitate dissolved and if this solution had no basic reaction, it was made alkaline with a saturated sodium hydroxide solution. Chloroacetyl chloride (6.1 ml, 0.080 mol) was added stepwise, in 4 parts over 20 min to the reaction mixture under vigorous stirring and cooling with water and ice; the stirring was continued for an additional 2 h. Then the mixture was acidified with concentrated hydrochloric acid (≈ pH 0) and the precipitated crude chloroacetamidophenoxyacetic acid was isolated by suction filtration and recrystalized from boiling water. The obtained crystals were dried at 60 °C under reduced pressure (0.93 kPa) for 4 h. 
2-[2-(2-Chloroacetamido)phenoxy]acetic acid (4)
.
2-{[2-(2-Oxo-1-azacycloalk-1-yl)acetamido]phenoxy}acetic acids.
Finely powdered potassium hydroxide (11.2 g, 0.20 mol) was suspended in 12 ml of dimethyl sulfoxide under stirring and 0.040 mol of the required lactam (i.e., 3.4 g of pyrrolidin-2-one, 4.0 g of piperidin-2-one and 4.5 g of azepan-2-one) were added. After stirring for 5 min, 2.4 g (0.010 mol) of the required chloroacetamidophenoxyacetic acid was added stepwise in 4-5 parts during 20 min under stirring. The mixture was stirred for an additional 2 h and then 140 ml of water was poured into it. The mixture was acidified with concentrated hydrochloric acid (≈ pH 0) and, after cooling to room temperature under stirring, it was left to crystallize in a refrigerator. After several days, the formed crystalline solid was filtered off and recrystallized from boiling water. The obtained crystals were dried at 60 °C under reduced pressure (0.93 kPa) for 4 h. 
Enzyme assay
L-Leucine-p-nitroanilide, C.A.S. 4178-93-2, a substrate for AP-M, was purchased from Bachem, Switzerland, and AP-M, isolated from porcine kidneys, 21 from Calbiochem, U.S.A. The other chemicals used were of analytical or biochemical grade. The absorbance values at 405 nm, which is the absorption maximum of 4-nitroaniline, a product of substrate hydrolysis catalyzed by AP-M, were measured on an SP 1800 UV-Vis spectrophotometer (Pye Unicam, U.K.). The results of the assays were evaluated and K i and IC 50 values were calculated using GraFit biochemical software (Erichaus, U.S.A.). The colorimetric assay of enzyme inhibition was performed according to a previously described procedure, 22 which is considered a standard analytical method for such a purpose, although some alternative approaches including RP-HPLC with fluorescence detection have also been successfully tested. 23 
RESULTS AND DISCUSSION
A homological series of 2-{[2-(2-oxo-1-azacycloalk-2-yl)acetamido]phenoxyacetic acids containing a 5-7-membered -lactam ring was prepared using a conventional synthetic procedure, which can be shortly described as the alkylation of o-, m-or p-nitrophenol with chloroacetic acid (both reactants in the form of their sodium salts), reduction of the resulting nitrophenoxyacetic acids to aminophenoxyacetic acids with ferrous ammonium sulfate, N-acylation of these amino acids with chloroacetyl chloride and alkylation of -lactams (in form of their potassium salts) with the resulting chloroacetamidophenoxyacetic acids.
For the reduction of the nitro groups to amino moieties, both catalytic hydrogenation on a palladium catalyst and reduction with stannous chloride were tested but only the 'traditional' reduction with a ferrous salt according to the method of Jacobs and Heidelberger 20 led to the desired products. Hydrogenation under normal pressure proceeded very slowly and gave a mixture of products while reaction with stannous chloride resulted in hardly cleavable coordination compound of an amino acid with a stannic cation.
The final step of the synthesis, the alkylation of a metallic salt of -lactam with chloroacetamidophenoxyacetic acid, was successful only when the potassium salt of the lactame was used with an excess of potassium hydroxide. The use of the sodium salt of the -lactam, which can be easily generated by the action of metallic sodium on the lactam in an aromatic solvent, led exclusively to the piperazine-2,5-dione derivative, i.e., 2,2'-[2,5-dioxopiperazine-1,4-diylbis-(4,1-phenyleneoxy)]bisacetic acid, which resulted from the mutual alkylation of two molecules of chloroacetamidophenoxyacetic acid. This reaction is enabled due to comparable N-H acidity of -lactams and the chloroacetamidic moiety, expressed by the equilibrium at the top of Scheme 2. The successful N-alkylation of the potassium salts of -lactams with compounds containing a chloroacetamidic group is probably the result of the larger volume and solvation ability of potassium cations in comparison with sodium cations (Scheme 2). The yields, melting points and spectral data of the prepared {[2-(2-oxo-1--azacycloalkyl)acetamido]phenoxy}acetic acids are given below. 
2-{2-[2-(2-Oxopyrrolidin-1-yl)acetamido]phenoxy}acetic acid (7)
